Bizarre Patents
An enclosure for small animals which is wearable on the front or back of an animate being.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7737261 | Avermectin B1 and avermectin B1 monosaccharide derivatives having an alkoxymethyl substituent in the 4″ -or 4′-position Avermectin B1 and avermectin B1 monosaccharide derivative compounds having an alkoxymethyl substituent in the 4″- or 4′-position; a process for preparing and using these compounds and their tautomers; pesticides whose active compound is selected from these compo... | 06/15/2010 |
| 7683161 | Selective reduction of spinosyn factors Et-J and Et-L to spinetoram Spinetoram is selectively produced in excellent yields by hydrogenating a mixture of 3′-O-ethyl spinosyn J and 3′-O-ethyl spinosyn L in a water miscible organic solvent using hydrogen gas and a heterogeneous catalyst. ... | 03/23/2010 |
| 7645863 | Method of purifying moxidectin through crystallization Methods for the purification of the macrolide moxidectin result in higher purity levels than can often otherwise be obtained. The crystalline moxidectin is then used in a wide variety of pharmaceutical and veterinary applications, including the prevention, treatment... | 01/12/2010 |
| 7378508 | Polymorphic crystalline forms of tiacumicin B The invention relates to novel forms of compounds displaying broad spectrum antibiotic activity, especially crystalline polymorphic forms and amorphous forms of such compounds, compositions comprising such crystalline polymorphic forms and amorphous forms of such co... | 05/27/2008 |
| 7365174 | Azalide and azalactam derivatives and method for producing the same Compounds represented by the general formula (1) or pharmaceutically acceptable salts thereof, effective in the prevention and/or treatment of infections with microbes: (1) (a) wherein R1 is hydrogen or straight-chain C1-6 alkylcarbonyl; R... | 04/29/2008 |
| 7358233 | Tetronic acid derivative The present inventors intended to search for substances that can regulate the expression of a molecular chaperone, GRP78, using the expression of GRP78 as an indicator. As a result, a novel tetronic acid derivative, versipelostatin compound (also known as JL68) show... | 04/15/2008 |
| 7348417 | Method of purifying moxidectin through crystallization Methods for the purification of the macrolide moxidectin result in higher purity levels than can often otherwise be obtained. The crystalline moxidectin is then used in a wide variety of pharmaceutical and veterinary applications, including the prevention, treatment... | 03/25/2008 |
| 7335753 | Bifunctional heterocyclic compounds and methods of making and using same The invention provides a family of bifunctional heterocyclic compounds useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The invention also provides methods of making the bifunctional heterocyclic compounds, and methods of using... | 02/26/2008 |
| 7312200 | 9-ketospinosyn derivatives The present invention relates to derivatives of 9-keto spinosyns, which are substituted by a ═N—(O, NH or NRx)—Ry moiety in the C-9 position, to methods for their manufacture, and to their use for controlling animal pests. ... | 12/25/2007 |
| 7309711 | Fungicidal agent combinations The invention relates to novel fungicidallly active compound combinations of 2′-cyano-3,4-dichloroisothiazole-5-carboxanilide of the formula and the active compounds listed in the disclosure. ... | 12/18/2007 |
| 7288572 | Active substance combinations having insecticidal and acaricidal properties The present invention relates to novel insecticidally and acaricidally active compound combinations of N2-[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide of the form... | 10/30/2007 |
| 7282221 | Antiviral product, use and formulation thereof An antiviral product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antiviral product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosag... | 10/16/2007 |
| 7259170 | Macrolides containing pharmaceutical compositions A pharmaceutical compound comprising a compound of formula I and a pharmaceutically acceptable 2-amino-1,3-propanediol beside one or more pharmaceutically acceptable excipient(s). ... | 08/21/2007 |
| 7250402 | Avermectin derivatives A compound represented by the general formula (I) or a salt thereof: wherein represents —CH═CH—, —CH2—CH2— or the like, | 07/31/2007 |
| 7247617 | Sixteen-member macrolide antiinfective agents Sixteen membered macrolide anti-infective agents having a structure according to formula I where R1, R2, R3, R4, R5, and R6 are as defined herein,... | 07/24/2007 |
| 7205289 | Combinations of active ingredients with insecticidal and acaricidal properties The invention relates to novel active compound combinations of certain cyclic ketoenols and certain insecticidally active compounds that together have very good insecticidal and acaricidal properties. ... | 04/17/2007 |
| 7160867 | Rapamycin carbohydrate derivatives This invention provides modified rapamycins that have specific monosaccharide(s), oligosaccharide(s), pseudosugar(s) or derivatives thereof attached through a linker to create rapamycin carbohydrate derivatives having enhanced pharmacokinetic and/or pharmacodynamic ... | 01/09/2007 |
| 7144866 | Avermectin derivatives Provided is a compound represented by the general formula (I) or a salt thereof: wherein, —XY— represents —CH═CH— and the like, between R2 and the carbon atom at 5-posi... | 12/05/2006 |
| 7141769 | Spectroscopy-based real-time control for microwave-assisted chemistry The invention is an instrument and method for microwave-assisted chemical synthesis. The instrument includes a source of microwave radiation for applying microwave energy to a sample, a microwave cavity in wave communication with the source for holding the sample du... | 11/28/2006 |
| 7135499 | Active substance combinations having insecticidal and acaricidal properties The present invention relates to novel insecticidally and acaricidally active compound combinations of N2-[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide of the form... | 11/14/2006 |
| 7129221 | 6,11-bicyclic erythromycin derivatives The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmace... | 10/31/2006 |
| 7122204 | Antibiotic composition with inhibitor Antibiotic composition having four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor, followed by release of the antibiotic followed by release of the inhibitor. I... | 10/17/2006 |
| 7034130 | Method for producing novel spinosyn derivatives The present invention relates to methods for producing novel spinosyn derivatives which are substituted with a 1-hydroxy-ethyl radical in the C-21 position and to novel spinosyn derivatives of this type per se and to their use for producing novel spinosyns. ... | 04/25/2006 |
| 6984515 | Macrolide analogs A polyketide or glycosylated polyketide which has the formula: wherein R* is methyl or ethyl; each of R1-R6 is methyl; X1 is OH or H; and/or X2 ... | 01/10/2006 |
| 6939892 | Compositions for treating or preventing malaria and method of treating malaria An antibiotic SF2487 substance having the formula (I) or a salt thereof possesses an antimalarial activity against the proliferation of malarial parasites and is therefore useful as an antimalarial drug. ... | 09/06/2005 |
| 6927210 | Ectoparasiticidal aqueous suspension formulations of spinosyns The invention provides a stable ectoparasiticidal aqueous suspension formulation of a spinosyn, comprising the spinosyn, or a physiologically acceptable derivative or salt thereof, milled to an average particle size of 1 to 15 microns, a surfactant in an amount effe... | 08/09/2005 |
| 6927057 | Macrolide analogs Combinatorial libraries of polyketides can be obtained by suitable manipulation of a host modular polyketide synthase gene cluster such as that which encodes the PKS for erythromycin. The combinatorial library is useful as a source of pharmaceutically active compoun... | 08/09/2005 |
| 6919317 | Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator Synergistic combinations of a squalene epoxidase inhibitor such as terbinafine and a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro, 33-desoxyascomycin are provided, which are useful in particular in the treatment of diseases involving fu... | 07/19/2005 |
| 6906184 | Process for antiparasitic agent An improved process for the preparation of the antiparasitic compound 25-cyclohexyl-22,23-dihydro-5-hydroxyiminoavermectin B1 monosaccharide from doramectine and intermediates therefor and crystalline solvates thereof. ... | 06/14/2005 |
| 6753415 | 23-O-substituted 5-O-mycaminosyltylonide derivatives There are described novel 5-O-mycaminosyltylonide (OMT) analogs possessing increased antibacterial activity toward Gram positive and Gram negative bacteria as well as macrolide resistant Gram positives and pharmaceutically acceptable compositions comprising a therap... | 06/22/2004 |
| 6747011 | Antitumor drugs and methods Derivatives of apoptolidin, including skeletal homologues, are potent and selective apoptosis-inducing agents which, unlike apoptolidin, do not undergo isomerization under physiological conditions. These compounds exhibit antitumor properties, often superior to thos... | 06/08/2004 |
| 6710034 | 5-O-mycaminosyltylonide derivatives There are described novel 5-O-mycaminosyltylonide derivatives and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier. Also described are a me... | 03/23/2004 |
| 6680299 | 4'-substituted leucomycins There are described novel 4' substituted 16-membered macrolides and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier. Also descr... | 01/20/2004 |
| 6680055 | Mycolactone and related compounds, compositions and methods of use The present invention provides, inter alia, polyketide macrolides including a polyketide macrolide of the structure ##STR1## wherein R1 -R5 are the same or different and each is independently selected from the group consisting of hyd... | 01/20/2004 |
| 6664237 | Oral treatment of companion animals with ectoparasiticidal spinosyns The invention provides single-dose oral formulations for controlling an ectoparasite infestation on a companion animal for a prolonged time, said formulations comprising a spinosyn component, or a physiologically acceptable derivative or salt thereof, and... | 12/16/2003 |
| 6664240 | Tylosin derivatives having antibacterial activity There are described novel substituted tylosin analogs and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier. Also described is a ... | 12/16/2003 |
| 6664241 | Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof The present invention provides two new classes of polyene macrolide amide derivatives useful for treating or preventing fungal infections. The new polyene macrolide amide derivatives exhibit antifungal activity and are more water-soluble than conventional... | 12/16/2003 |
| 6660718 | 3-modified leucomycin derivatives A compound represented by the following general formula (I) or a salt thereof: ##STR1## wherein R represents a C1-C10 alkyl group, a C3-C10 alkenyl group, a C7-C15 aralkyl group, a quinolinylalkyl group, a quinolinylalkenyl group, a... | 12/09/2003 |
| 6649630 | Methods and compositions controlling pests The present invention provides compositions and methods which can provide a pesticidal effect. The compositions typically comprise 4-phenoxyphenyl 2-(2-pyridyloxy)propyl ether and an ether compound encompassed by formula I: ##STR1## wherein R rep... | 11/18/2003 |
| 6613747 | 6-O-carbamoyl ketolide antibacterials 6-O-Carbamoyl ketolide antibacterials of the formula: ##STR1## wherein R1, R2, R3, R4, R5, R6, X, X', Y, and Y' are as described herein and in which the substituents have the meaning indica... | 09/02/2003 |
